Iovance: Down And Rebound
Despite recent uncertainty, Iovance made a huge comeback announcing superb data for its lead franchise, lifileucel. Read more on why I believe IOVA stock has more…
Despite recent uncertainty, Iovance made a huge comeback announcing superb data for its lead franchise, lifileucel. Read more on why I believe IOVA stock has more…
These pharmaceutical companies might make great long-term additions to your portfolio.
This digital advertising platform is well-positioned for multi-year growth.
Zoom is one of several popular stocks that will announce earnings results over the next few days.
Many retail analysts and pundits fear that the Q1 sales recovery wasn’t sustainable, but the evidence suggests that sales trends will strengthen further over the…
Cimarex Energy (XEC) all-stock merger with Cabot Oil & Gas (COG) didn’t get the reception the companies likely expected after it was unveiled on Monday.No less…
Sky-high valuations don’t mean that returns have to be negative going forward, Goldman Sachs analysts said.
It’s certainly possible, but you have to commit to making some sacrifices now for the big payoff later.
From unexpected medical costs to supporting adult children, Americans often find themselves facing expenses they weren’t anticipating in their golden years.